FMR LLC 13D and 13G filings for Avidity Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-09 08:35 am Sale | 2024-02-08 | 13G | Avidity Biosciences, Inc. RNA | FMR LLC | 10,404,096 14.040% | -218,767 (-2.06%) | Filing |
| 2023-07-10 10:20 am Purchase | 2023-07-07 | 13G | Avidity Biosciences, Inc. RNA | FMR LLC | 10,622,863 14.999% | 5,697,486 (+115.68%) | Filing |
| 2023-02-09 08:23 am Purchase | 2023-02-09 | 13G | Avidity Biosciences, Inc. RNA | FMR LLC | 4,925,377 7.412% | 1,148,853 (+30.42%) | Filing |
| 2022-02-09 09:09 am Purchase | 2022-02-08 | 13G | Avidity Biosciences, Inc. RNA | FMR LLC | 3,776,524 8.052% | 352,389 (+10.29%) | Filing |
| 2021-02-08 10:17 am Purchase | 2021-02-05 | 13G | Avidity Biosciences, Inc. RNA | FMR LLC | 3,424,135 9.124% | 591,283 (+20.87%) | Filing |
| 2020-07-10 11:38 am Purchase | 2020-07-09 | 13G | Avidity Biosciences, Inc. RNA | FMR LLC | 2,832,852 7.552% | 909,887 (+47.32%) | Filing |
| 2020-06-19 10:30 am Purchase | 2020-06-19 | 13G | Avidity Biosciences, Inc. RNA | FMR LLC | 1,922,965 5.439% | 1,922,965 (New Position) | Filing |